Inhaled human insulin (Exubera®): clinical profile and patient considerations

Inhaled human insulin (Exubera®) is a rapid-acting regular human insulin administered by oral inhalation before meals. It provides a non-invasive alternative to multiple subcutaneous injections for the treatment of hyperglycemia in adult patients with type 1 and type 2 diabetes. Compared with subcut...

Descripción completa

Detalles Bibliográficos
Autores principales: Barnett, Anthony H, Bellary, Sri
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2007
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1994047/
https://www.ncbi.nlm.nih.gov/pubmed/17583178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1994047/
https://www.ncbi.nlm.nih.gov/pubmed/17583178

Ejemplares similares